The Net Margin of Medite Cancer Diagnostics Inc (MDIT) is -99.97%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2017-12-31 | -99.97% |
2016-12-31 | -23.41% |
2015-12-31 | -8.69% |
2014-12-31 | -6.36% |
2013-12-31 | 0.54% |
2012-12-31 | -764.65% |
2011-12-31 | -14400.00% |
2010-12-31 | -7000.00% |
2009-12-31 | -8875.00% |
2008-12-31 | -4869.23% |